BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27633613)

  • 21. CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: pharmacogenetics and anthropological implications.
    Griman P; Moran Y; Valero G; Loreto M; Borjas L; Chiurillo MA
    Ann Hum Biol; 2012 Mar; 39(2):137-42. PubMed ID: 22324840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.
    Müller DJ; Kekin I; Kao AC; Brandl EJ
    Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
    Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
    Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
    Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
    Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.
    Bahar MA; Setiawan D; Hak E; Wilffert B
    Pharmacogenomics; 2017 May; 18(7):701-739. PubMed ID: 28480783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
    Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
    J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.
    Peñas-LLedó E; Terán E; Sosa-Macías M; Galaviz-Hernández C; Gil JP; Nair S; Diwakar S; Hernández I; Lara-Riegos J; Ramírez-Roa R; Verde I; Tarazona-Santos E; Molina-Guarneros J; Moya G; Rägo L; LLerena A
    Clin Ther; 2020 Aug; 42(8):1595-1610.e5. PubMed ID: 32782137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.
    Campbell NL; Skaar TC; Perkins AJ; Gao S; Li L; Khan BA; Boustani MA
    Clin Interv Aging; 2015; 10():269-75. PubMed ID: 25609939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of cardiovascular pharmacogenetics.
    Voora D; Ginsburg GS
    J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
    Mas S; Gassó P; Torra M; Bioque M; Lobo A; González-Pinto A; Olmeda MS; Corripio I; Vieta E; Castro-Fornieles J; Rodriguez-Jimenez R; Bobes J; Usall J; Llerena A; Saiz-Ruiz J; Bernardo M; Lafuente A; PEPs Group
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):647-656. PubMed ID: 28389049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene flow among Anopheles albimanus populations in Central America, South America, and the Caribbean assessed by microsatellites and mitochondrial DNA.
    Molina-Cruz A; de Mérida AM; Mills K; Rodríguez F; Schoua C; Yurrita MM; Molina E; Palmieri M; Black WC
    Am J Trop Med Hyg; 2004 Sep; 71(3):350-9. PubMed ID: 15381818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental Biology in Central America, the northern region of South America and the Caribbean.
    García-Arrarás JE
    Int J Dev Biol; 2021; 65(1-2-3):49-58. PubMed ID: 32930372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is pharmacogenetic CYP2D6 testing useful?
    Vetti HH; Molven A; Eliassen AK; Steen VM
    Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 36. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacoeconomic and pharmacogenetic aspects of the implementation of a personalized approach in the treatment of cardiac patients].
    Gruzdeva AA; Khokhlov AL; Ilyin MV; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1258-1263. PubMed ID: 34792874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?
    Pineda-Peña AC; Bello DC; Sussmann O; Vandamme AM; Vercauteren J; van Laethem K; Gómez-López A
    AIDS Rev; 2012; 14(4):256-67. PubMed ID: 23258300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study.
    Madadi P; Joly Y; Avard D; Chitayat DC; Smith MA; D Ross CJ; Carleton BC; Hayden MR; Koren G
    J Popul Ther Clin Pharmacol; 2011; 18():e152-5. PubMed ID: 21467605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of bioinformatics training applied to research in molecular medicine, agriculture and biodiversity in Costa Rica and Central America.
    Orozco A; Morera J; Jiménez S; Boza R
    Brief Bioinform; 2013 Sep; 14(5):661-70. PubMed ID: 23723382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.